Comparison of Efficacy & Safety of Intravaginal Misoprostol Tablet and Intracervical Dinoprostone Gel for Induction of Labour in Unfavourable Cervix in Term Pregnancy: A Randomised Control Trial
Authors/Creators
- 1. Assistant Professor in Dept of Obs Gyn, Command Hospital Airforce, Bangalore, Karnataka
- 2. Associate Professor and ART Spl, Dept of Obs Gyn, Command Hospital Airforce, Bangalore, Karnataka
Description
Background: Induction of labour is a commonly performed obstetrical procedure for which numerous methods are adapted and intracervical dinoprostone and intravaginal misoprostol are the most frequently used techniques. This study aimed to compare the safety and efficacy intravaginal misoprostol tablet and intracervical dinoprostone gel for induction of labour at term. Methods: The present study was conducted in a tertiary care hospital in New Delhi among pregnant females with singleton pregnancy at term requiring induction of labour for various indications. The study subjects were enrolled in group A (misoprostol group) were administered 25 mcg of misoprostol every 4th hourly to a maximum of 5 doses and in group B (dinoprostone) study subjects were administered 0.5 mg of dinoprostone every 6th hourly to a maximum of 4 doses. Results: A total of 50 cases were enrolled in both the study groups. The baseline parameters among both the study groups were comparable. Nearly two-third of study subjects in misoprostol group delivered within first 12 hours and only 12% had delivered in first 12 hours in dinoprostone group. Requirement of oxytocin augmentation of labour was nearly similar in both the study with 18% of cases in misoprostol group and 16% cases in dinoprostone group requiring it. Conclusion: Low dose vaginal misoprostol is associated with a lower incidence of uterine tachysystole and a lower caesarean delivery rate.
Abstract (English)
Background: Induction of labour is a commonly performed obstetrical procedure for which numerous methods are adapted and intracervical dinoprostone and intravaginal misoprostol are the most frequently used techniques. This study aimed to compare the safety and efficacy intravaginal misoprostol tablet and intracervical dinoprostone gel for induction of labour at term. Methods: The present study was conducted in a tertiary care hospital in New Delhi among pregnant females with singleton pregnancy at term requiring induction of labour for various indications. The study subjects were enrolled in group A (misoprostol group) were administered 25 mcg of misoprostol every 4th hourly to a maximum of 5 doses and in group B (dinoprostone) study subjects were administered 0.5 mg of dinoprostone every 6th hourly to a maximum of 4 doses. Results: A total of 50 cases were enrolled in both the study groups. The baseline parameters among both the study groups were comparable. Nearly two-third of study subjects in misoprostol group delivered within first 12 hours and only 12% had delivered in first 12 hours in dinoprostone group. Requirement of oxytocin augmentation of labour was nearly similar in both the study with 18% of cases in misoprostol group and 16% cases in dinoprostone group requiring it. Conclusion: Low dose vaginal misoprostol is associated with a lower incidence of uterine tachysystole and a lower caesarean delivery rate.
Files
IJPCR,Vol15,Issue9,Article35.pdf
Files
(389.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:0d30629e7ddcbe6be2cc007a2d4934dc
|
389.0 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-08-25
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue9,Article35.pdf
- Development Status
- Active
References
- 1. WHO recommendations: induction of labour at or beyond term. Geneva: World Health Organization; 2018. Available from: https://apps.who.int/iris/bitstream/handle/1066 5/277233/9789241550413-eng.pdf. Accessed on 26 Nov 2022. 2. Luckas M, Bricker L. Intravenous prostaglandin for induction of labour. Cochrane Database Syst Rev. 2000; 2000 (4):CD002864. 3. Kelly AJ, Tan B. Intravenous oxytocin alone for cervical ripening and induction of labour. Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD003246. 4. Kelly AJ, Kavanagh J, Thomas J. Castor oil, bath and/or enema for cervical priming and induction of labour. Cochrane Database Syst Rev. 2013 Jul 24;2013(7):CD003099. 5. Boulvain M, Kelly A, Lohse C, Stan C, Irion O. Mechanical methods for induction of labour. Cochrane Database Syst Rev. 2012 Mar 14;(3):CD001233. 6. Neilson JP. Mifepristone for induction of labour. Cochrane Database Syst Rev. 2009 Jul 8, 2009(3):CD002865. 7. Muzonzini G, Hofmeyr GJ. Buccal or sublingual misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev. 2004 Oct 18;2004(4):CD004221. 8. Alfirevic Z, Weeks A. Oral misoprostol for induction of labour. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD001338. 9. Smith CA, Crowther CA, Grant SJ. Acupuncture for induction of labour.Cochrane Database Syst Rev. 2017 Oct 17;10(10):CD002962. 10. Kelly AJ, Kavanagh J, Thomas J. Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD003101. 11. Hofmeyr GJ, Gülmezoglu AM, Pileggi C. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev. 2010 Oct 6;2010(10):CD000941. 12. Kavanagh J, Kelly AJ, Thomas J. Breast stimulation for cervical ripening and induction of labour. Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD003392. 13. Kavanagh J, Kelly AJ, Thomas J. Corticosteroids for cervical ripening and induction of labour. Cochrane Database Syst Rev. 2006 Apr 19;2006(2):CD003100. 14. Pierce S, Bakker R, Myers DA, Edwards RK. Clinical Insights for Cervical Ripening and Labor Induction Using Prostaglandins. AJP Rep. 2018 Oct;8(4):e307-e14. 15. Walt RP. Misoprostol for the treatment of peptic ulcer and anti-inflammatory-druginduced gastro duodenal ulceration. N Engl J Med. Nov 26, 1992;327(22):1575–80. 16. Lakshmidevi S, Lakshmidevi K. The comparative study of intravaginal misoprostol and intracervical prostaglandin E2 gel for induction of labour. Indian J Obstet Gynecol. 2017;5(4):462-5 17. Middleton P, Shepherd E, Crowther CA. Induction of labour for improving birth outcomes for women at or beyond term. Cochrane Database Syst Rev. 2018 May 9;5(5):CD004945. 18. Chatsis V, Frey N. Misoprostol for Cervical Ripening and Induction of Labour: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Nov 23. 19. Austin SC, Sanchez-Ramos L, Adair CD. Labor induction with intravaginal misoprostol compared with the dinoprostone vaginal insert:a systematic review and meta-analysis. Am J Obstet Gynecol. 2010 Jun;202(6):624.e1-9. 20. Cheng SY, Ming H, Lee JC. Titrated oral compared with intracervical dinoprostone for induction: a randomized controlled trial. Obstet Gynecol. 2008: 111 (1): 119-125. 21. Raval BM, Zalavadiya NS, Yadava PA, Mehta ST. Comparative study of intra vaginal misoprostol (PGE1) with intracervical dinoprostone (PGE2) gel for induction of labour. Int J Reprod Contracept Obstet Gynecol. 2018;7:3769-73. 22. Das D, Medhi R, Chowdhury N. Comparison between effectiveness of sublingual misoprostol and intracervical dinoprostone gel for induction of labour in pregnant women.Int J Res Med Sci. 2023;11:2134-9. 23. Khan R, El-Refaey H, Sharma S, Sooranna D, Stafford M. Oral, rectal and vaginal pharmacokinetics of misoprostol. Obstet Gynaecol. 2004;103:866–70. 24. Suman D, Singh T, Singh S. A Randomised Comparative Study of Vaginal Misoprostol and Intracervical Cerviprime Gel for Induction of Labor. Ann. Int. Med. Den. Res. 2021; 7(2):OG05-OG08. 25. Kundodyiwa TW, Alfirevic Z, Weeks AD. Low dose vaginal misoprostol for induction of labour: a systematic review. Obstet Gynecol. 2009; 113 (2 Pt 1): 374-383.